Platelet derived growth factor receptor (pdgfr) antibodies, conjugates, compositions, and uses thereof
AssigneeBiorion Technologies B.V.
InventorsHermannus STEEN, Gustaaf Johan Marie VAN SCHARRENBURG
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiorion Technologies B.V.
InventorsHermannus STEEN, Gustaaf Johan Marie VAN SCHARRENBURG
Estimating the term…
The invention relates to antibodies against the Platelet Derived Growth Factor Receptor beta (PDGFR β), and the use thereof in diagnostic and/or therapeutic applications. In particular, it provides a (VHH) antibody that specifically binds PDGFR β with an apparent binding affinity of less than 10 nM, preferably less than 5 nM, and which does not activate PDGFR β. Also provided are PDGFR β antibodies and conjugates thereof, and their application in the targeted delivery of a diagnostic agent, a therapeutic agent or a combination thereof to a tissue in a subject, in particular to fibrotic tissue comprising activated myofibroblasts.
An antibody that specifically binds to the Platelet-derived growth factor receptor beta (PDGFR β) with a binding affinity of less than 10 nM.
Dependencies are inferred from the claim text.